Group items tagged

Do you want to be aware of symptoms and treatment for psychological withdrawal? Read our latest blog to know how to overcome from these symptoms. Here are some methods for treating psychological withdrawal during the early stages of recovery. Learn more!

Do you want to be aware of symptoms and treatment for psychological withdrawal? Read our latest blog to know how to overcome from these symptoms. Here are some methods for treating psychological withdrawal during the early stages of recovery. Learn more!

Adderall is a prescription drug used for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD). Anyone under this prescription must not share it with an individual with a history of drug or substance abuse. If you took large doses of Adderall for prolonged periods and decide to stop taking this drug, the withdrawal stage could bring many Adderall withdrawal symptoms. Let\'s check out the several and serious side effects of Adderall addiction!

Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help Europe meet its public health priorities. In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic products, as per Teva Pharmaceuticals' recent analysis of IQVIA data. Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the availability of generic cancer medicines in just six years (2017-2022). These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause "significant harm to patients and pose important challenges to health systems." While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding Europe's public health, the Teva analysis report noted. Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria experiencing the biggest loss at 83 per cent and 58 per cent respectively.

Community pharmacies are bracing themselves to withdraw services from patients after an industry ballot supported plans for major action unless the government provided a significant increase in funding for the sector. The National Pharmacy Association (NPA) on Tuesday (12) announced the results of an unprecedented collective action ballot in which nearly all pharmacy owners, who participated in the ballot, voted to limit their services, insisting that a lack of additional funding is jeopardising patients health and safety. Over 63 per cent of NPA members in England, Wales and Northern Ireland took part in the ballot- representing 3,049 independent community pharmacies in England alone, or 3,399 with Wales and Northern Ireland included. Nearly 98 per cent of pharmacy owners in England voted to reduce their opening hours to the minimum required by their contract. This could result in fewer pharmacies remaining open during evenings and weekends. More than 93 per cent voted to stop offering "unfunded" free home deliveries of medicines, and over 96 per cent voted to withdraw from locally commissioned services, including certain addiction support, emergency contraception, and stop smoking services.

Coeliac UK has raised grave concerns about the decision by NHS Leicester, Leicestershire and Rutland Integrated Care Board (ICB) to withdraw gluten free prescriptions for people with a diagnosis of coeliac disease and its potential impact on their health. The charity highlighted the significant additional cost of gluten free staple substitute products, which poses a real challenge to maintaining the gluten free diet, the only treatment for the condition. Coeliac UK noted that 72 per cent of respondents to a recent public consultation disagreed with the ICB's proposal to stop gluten free prescribing, and said it is "deeply concerned" by the potential impact of the decision to proceed with removal of provision. The charity accused the ICB of making no meaningful effort to reduce the impact of this policy change for those on low incomes, despite the additional cost of gluten free food being highlighted by 58 per cent of those who disagreed with the proposal.

If you know somebody who is regularly binge drinking, it can be difficult to know how to help them. Binge drinking is a serious problem, and can have devastating consequences for the individual involved. This blog post will discuss the signs of binge drinking and provide some tips on how you can help somebody who is struggling with this addiction. 1. FIND THEM A DETOX CENTER If you are concerned that somebody you know is regularly binge drinking, one of the best things you can do is to find them a detox center. Detox centers provide a safe and supervised environment for people to detox from alcohol. They will also be able to provide support and resources to help the individual in their recovery. As professionals at https://www.northridgedetoxcenter.com/ explain, detox centers can offer many different services to help people through the withdrawal process. These services may include medical detox, which can help to manage the symptoms of withdrawal, and counseling services, which can provide support and guidance during this difficult time. It is important to remember that detox is just the first step in recovery and that the individual will need to continue to receive treatment after they have completed detox.

Lloyds Pharmacy announced the withdrawal of pharmacy services from all Sainsbury's stores over mounting "industry pressures" faced by the community pharmacies. The company had 77 branches at the beginning of this year - out of which five branches closed their doors and transferred the ownership of the remaining 72 to others. It was announced in June this year that Lloyds Pharmacy branches in Sainsbury's will close its operation throughout 2023. The following decision came after "changing market conditions" put 2,000 jobs on the line across the UK. Four Lloyds Pharmacies inside Wales Sainsbury's stores closed within days of the announcement and one in the Roath suburb of Cardiff as well. The remaining 72 changed hands as confirmed by the figures obtained by WalesOnline on 5 October.

NHS West Yorkshire Integrated Care Board (ICB)'s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale has disappointed Coeliac UK. In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised "grave concerns" about the decision, warning that it will have a detrimental impact on the coeliac community. The policy is currently implemented across the ICB's other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac patients from accessing gluten free bread and flour mix on prescription. NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places. But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the only treatment for the condition.

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the permanent register, the General Pharmaceutical Council has said. The government asked the GPhC and other pertinent health professional regulators to close temporary registers by March 31, 2024. According to the GPhC, this decision is based on the anticipation that the emergency conditions justifying the establishment of these temporary registers will cease after the approaching winter. The temporary register was established after the Health and Social Care Secretary asked the Council to utilise its emergency powers to swiftly register pharmacy professionals for their essential role in the national COVID-19 response. Pharmacists and pharmacy technicians who had previously opted to withdraw from the GPhC register or failed to renew their registration are now eligible for immediate re-registration, the regulator added.

Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday (Aug 12) after the companies said that nothing material had changed regarding US litigation focused on heartburn drug Zantac. The companies' share prices had fallen sharply last week on investor concern about the litigation over potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020. More than 2,000 Zantac-related legal cases have been filed in the United States, analysts say, with the first trial beginning this month. The prospect of impending Zantac litigation is not new. Among other disclosures, recently listed Haleon had highlighted the risk of such lawsuits in its prospectus. GSK, Sanofi, Pfizer and Haleon have lost a combined $39 billion from their market value over the past week in the absence of any other particular catalyst, according to Barclays analysts.

Pharmacists can dispense Paracetamol 120mg suppositories in accordance with the prescription, as the Department of Health and Social Care (DHSC) has confirmed that sufficient stocks are available to meet normal demand. This means the Serious Shortage Protocol - SSP033 - for Paracetamol 120mg suppositories has now expired since 26 August 2022. Top tips for SSP claims NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous - NHSBSA processing staff must be able to determine what has been supplied. NHSBSA have published information on common SSP endorsing errors they see when processing claims. Any paper prescriptions with SSP claims need to be placed in the red separator provided by the NHSBSA. Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP to help manage any owings for other items issued on the same prescription form. For example, for SSP033 Paracetamol 120mg suppositories, which expires at 23.59pm on Friday 26 August 2022, the NHSBSA would continue to look for the "SSP" endorsement on prescriptions for Paracetamol 120mg suppositories that are submitted with the August batch (submitted by 5 September), September batch (submitted by 5 October) and October batch (submitted by 5 November).

The Medicines and Healthcare products Regulatory Agency (MHRA) has cautioned people to stop using certain eye gels, highlighting a potential risk of microbial contamination that can cause an infection. As a precaution, the agency on Friday announced recall of specific batches of carbomer-containing lubricating eye gels branded Aacarb, Aacomer and Puroptics, which are generally used to relieve the symptoms of dry eye. Burkholderia cenocepacia is suspected to have caused the microbial contamination, and the issue was raised after an ongoing investigation conducted by UK Health Security Agency (UKHSA) identified a small number of cases of infection. Investigations are on to determine if there is a link between these products and the infections which have been identified. Meanwhile, retailers have been told to withdraw the affected products, and users are asked to return their product to the place of purchase immediately.

The National Institute for Health and Care Excellence (NICE) has issued draft guidance on 'Evusheld' which is not recommended for vulnerable adult with high risk of severe Covid-19 on Thursday (16 February). The draft guidance is open for public consultation until 9 March 2023. The committee will consider any comments received at a meeting currently due to take place on 4 April 2023. It comes after last month's decision by the US drug regulator to withdraw its emergency use authorisation for Evusheld as a preventative treatment for Covid-19, which said there was insufficient evidence that Evusheld is effective against the dominant variants of Covid-19 in the US. NICE's independent appraisal committee has reached the same conclusion having considered evidence which shows Evusheld is unlikely to prevent infection with most of the variants circulating in the UK now and in the near future. It has also announced that it is developing a new review process to update recommendations on the cost-effectiveness of Covid-19 treatments so they can be made available more quickly to patients if they show promise against new variants and are found to be cost-effective.

Generic and over-the-counter drugs company Stada has asked the German government to seek assurances from Ukraine that the company can continue operations there even though it also does business in Russia. In a March 21 letter to German Economy Minister Robert Habeck, Stada CEO Peter Goldschmidt said there was a risk Kyiv might withdraw the company's market authorisation. Stada "still has no longer-term certainty that we will be able to sell our products in Ukraine in the future," the letter said, with the subject line: "Please prevent the exclusion of international pharmaceutical companies from the Ukrainian market." The Economy Ministry did not have an immediate comment on the letter. Habeck promised investment guarantees for German companies during a trip to Ukraine on Tuesday (April 4) as part of his goal to speed up reconstruction in the war-torn country. Goldschmidt said restricting Stada's operations would be bad for Ukraine.

A group of 20 MPs from the different political parties, including Dame Priti Patel and Judith Cummins, have written a joint letter to health minister Andrea Leadsom, calling for urgent action to address the pressures faced by community pharmacies. Taking note of rising pharmacy closures, they have highlighted the need for more investment and support from the government. Recent NHS figures showed that around 1,400 pharmacies have closed permanently since October 2016, and many more are withdrawing services or reducing their opening hours, particularly in deprived areas. The MPs have urged the pharmacy minister to commit to making essential changes including a fair and sustainable core funding model, an effective implementation of the Pharmacy First service and an expansion into other clinical service areas.

Online vape store GoSmokeFree analysed data from NHS Stop Smoking Service in England from April to September 2023 to determine the number of individuals in each of the nine UK regions who reported successfully quitting smoking after setting a quit date. The findings showed that the South East has the highest number of successful quitters, with 1,226 smokers per 100,000 reporting to have given it up. The Isle of Wight is the most successful area to quit smoking in the South East with 3,124 people quitting per 100,000 smokers. Of the 4,294 individuals who set a quit date in this region, 803 admitted to not being able to achieve their target. A spokesperson from the online retailer noted that overcoming nicotine withdrawals and mental challenges can be exceptionally difficult when attempting to quit smoking.

The National Pharmacy Association (NPA) will ask its members to vote on taking industrial action in order to bring to the public's attention the "slow death of community pharmacy", the organisation's chief executive has told Pharmacy Business. The NPA, which represents 6,000 community pharmacies across the UK, announced today that it will be sending a formal ballot to its members to vote on work to rule plans to protest against a decade of cuts to pharmacy funding. The ballot will ask pharmacies to consider a range of actions if the financial situation for pharmacies does not improve. This includes, reduction in services; cut hours to contract minimums; withdraw free deliveries or end the provision of free blister packs; cease to share data with the NHS unless it's a legal requirement; and consider serving notice on a range of locally contracted services, negotiated directly with local authorities. The ballot will be open for responses for six weeks and any action supported by a majority of pharmacies could take place before Christmas.

In significant development, the Pharmacists' Defence Association (PDA) has advised its Boots members to challenge the "trustees' decision to end the ability to take an unreduced pension from age 60 by submitting complaints through the scheme's two-stage internal disputes procedure". The issue centers around the alterations made to pension scheme rules without the adequate disclosure to scheme members or their representatives. The PDA has drafted template letters to assist scheme members in response to undisclosed changes during a buyout process, sparking legal challenges and demands for transparency from Boots and scheme trustees. Paul Moloney, National Officer of the PDA Union leading the campaign, expressed concern over the sudden withdrawal of the right to an unreduced pension from age 60. "We have always maintained that members had a right under the rules to draw an unreduced pension from age 60," Moloney stated.

Hallo Healthcare has announced its decision to exit from its hospital pharmacy sites, currently operated by LloydsPharmacy Healthcare Services (LP HCS Limited), which primarily provides outpatient services. Pharmacists and their teams at its 64 pharmacy sites were informed on Monday, 19 August 2024, about the company's plans to withdraw from this sector. The Pharmacists' Defence Association (PDA), the recognised trade union representing pharmacists at these sites, was also notified. The association has assured its support for members impacted by the decision, although it noted that the process of branch transfers could take several months. "It is expected to be several months before all such branch transfers are agreed and undertaken," the PDA said. The association noted that contracts to provide such services "do change hands periodically with some hospital outpatient departments (OPDs) operated by pharmacy multiples and others operated by hospital-owned subsidiaries" and highlighted its experience in supporting pharmacists when employers change in this way. PDA Union Director Paul Day is hopeful that there will be no job losses in outpatient services and that all pharmacists will be able to continue in their current roles.